1. Lejeune, F.J.: Phase III adjuvant studies in operable malignant melanoma (review). Anticancer Res.7:701, 1987
2. Coates, A.S., Durant, J.R.: Chemotherapy for metastatic melanoma. In Cutaneous Melanoma: Clinical Management and Treatment Results Worldwide, C.M. Balch, G.W. Milton, editors, Philadelphia, Lippincott, 1985, pp. 275–282
3. Coates, A.S., Rümke, P.: Chemotherapy: New chemotherapeutical agents. In Surgical Management of Malignant Melanoma, F.J. Lejeune, P.K. Chaudhuri, T. Das Gupta, editors, New York, Pergamon Press, 1991
4. Malden, T., Coates, A.S., McCarthy, W.H., Milton, G.W.: Phase II study of mitolactol in the treatment of metastatic malignant melanoma. Cancer Treat. Rep.68:1045, 1984
5. Coates, A.S., Bishop, J., Mann, G.J., Raghavan, D.: Chemotherapy in metastatic melanoma: Phase II studies of amsacrine, mitozantrone and bisantrene. Eur. J. Cancer Clin. Oncol.22:97, 1986